Waters Co. (NYSE:WAT) SVP Elizabeth B. Rae sold 16,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $177.21, for a total transaction of $2,835,360.00. Following the transaction, the senior vice president now directly owns 14,129 shares of the company’s stock, valued at $2,503,800.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Waters Co. (NYSE:WAT) traded down 0.20% during mid-day trading on Friday, reaching $178.25. 106,757 shares of the company’s stock were exchanged. Waters Co. has a one year low of $131.35 and a one year high of $179.07. The company’s 50-day moving average price is $168.21 and its 200-day moving average price is $151.06. The company has a market capitalization of $14.27 billion, a PE ratio of 27.11 and a beta of 0.83.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, April 25th. The medical instruments supplier reported $1.46 EPS for the quarter, beating the consensus estimate of $1.33 by $0.13. Waters had a net margin of 24.06% and a return on equity of 24.47%. The business had revenue of $497.97 million during the quarter, compared to analysts’ expectations of $489.37 million. During the same period in the previous year, the business posted $1.26 EPS. The business’s quarterly revenue was up 4.8% compared to the same quarter last year. On average, equities analysts expect that Waters Co. will post $7.31 earnings per share for the current year.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

WARNING: This article was reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/05/26/waters-co-wat-svp-elizabeth-b-rae-sells-16000-shares.html.

Hedge funds have recently made changes to their positions in the stock. Creative Planning boosted its stake in shares of Waters by 1.6% in the first quarter. Creative Planning now owns 744 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 12 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Waters by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 822 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 35 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Waters by 7.2% in the fourth quarter. Van ECK Associates Corp now owns 1,051 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 71 shares during the last quarter. Advisory Services Network LLC acquired a new stake in shares of Waters during the first quarter valued at approximately $169,000. Finally, Parallel Advisors LLC acquired a new stake in shares of Waters during the fourth quarter valued at approximately $177,000. Institutional investors and hedge funds own 92.53% of the company’s stock.

Several research firms have recently weighed in on WAT. Barclays PLC set a $160.00 price objective on shares of Waters and gave the company a “hold” rating in a report on Wednesday, April 26th. Cantor Fitzgerald reissued a “buy” rating and set a $190.00 price objective (up from $170.00) on shares of Waters in a report on Tuesday, April 25th. Cowen and Company boosted their price objective on shares of Waters from $160.00 to $175.00 and gave the company a “market perform” rating in a report on Wednesday, April 26th. Zacks Investment Research raised shares of Waters from a “sell” rating to a “hold” rating in a report on Thursday, January 26th. Finally, Evercore ISI cut shares of Waters from a “hold” rating to an “underperform” rating in a report on Friday, March 3rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $168.91.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

12 Month Chart for NYSE:WAT

Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with MarketBeat.com's FREE daily email newsletter.